Ascent Wealth Partners’s Eli Lilly LLY Stock Holding History

Ascent Wealth Partners’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-8,706	Closed	-$8.01M	–	201
2026 Q1	$8.01M	Buy	8,706 +540	+7%	+$547K	0.93%	33
2025 Q4	$8.78M	Buy	8,166 +40	+0.5%	+$38.2K	1.01%	31
2025 Q3	$6.2M	Buy	8,126 +4,962	+157%	+$3.69M	0.72%	45
2025 Q2	$2.47M	Sell	3,164 -875	-22%	-$680K	0.3%	69
2025 Q1	$3.34M	Buy	4,039 +30	+0.7%	+$25K	0.45%	54
2024 Q4	$3.09M	Buy	4,009 +119	+3%	+$98.5K	0.42%	55
2024 Q3	$3.45M	Buy	3,890 +599	+18%	+$539K	0.48%	49
2024 Q2	$2.98M	Buy	3,291 +1,699	+107%	+$1.36M	0.44%	53
2024 Q1	$1.21M	Buy	+1,592	New	+$1.13M	0.18%	102

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ascent Wealth Partners's LLY Position: Q2 2026 in Review

Ascent Wealth Partners sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 8,706 shares — an estimated $8.01M sold.

Ascent Wealth Partners first reported a position in LLY in Q1 2024 and held it in 9 quarters. The position peaked at $8.78M in Q4 2025. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Ascent Wealth Partners reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
Ascent Wealth Partners sold 8,706 Eli Lilly shares in Q2 2026, an estimated $8.01M.
Ascent Wealth Partners first reported a position in Eli Lilly in Q1 2024 and held it in 9 quarters.
Ascent Wealth Partners's Eli Lilly position peaked at $8.78M in Q4 2025.
4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Ascent Wealth Partners's 13F filing for Q2 2026, filed 31 Jul 2026.